BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7470582)

  • 1. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.
    Ahlemann LM; Staab HJ; Anderer FA
    Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
    Staab HJ; Ahlemann LM; Koch HL; Anderer FA
    Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
    Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
    Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen (CEA) measurements as an aid to management of patients with lung cancer treated by radiotherapy.
    Ahlemann LM; Staab HJ; Koch HL; Anderer FA
    Oncodev Biol Med; 1980; 1(3):143-50. PubMed ID: 7279701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer].
    Paulick R; Caffier H
    Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy.
    Paulick R; Caffier H
    Cancer Detect Prev; 1988; 11(3-6):311-7. PubMed ID: 3390852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
    Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
    Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
    Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
    J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.
    Tondini C; Hayes DF; Gelman R; Henderson IC; Kufe DW
    Cancer Res; 1988 Jul; 48(14):4107-12. PubMed ID: 3164256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial CEA and CA 15-3 measurements during follow-up of breast cancer patients.
    Jäger W; Eibner K; Löffler B; Gleixner S; Krämer S
    Anticancer Res; 2000; 20(6D):5179-82. PubMed ID: 11326691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year follow-up of carcinoembryonal antigen levels in the serum of patients with breast cancer.
    Lang BA; Kocent A; Nekulová M; Hlávková J
    Neoplasma; 1984; 31(1):79-87. PubMed ID: 6700798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy.
    Falkson HC; van der Watt JJ; Portugal MA; Schoeman HS; Falkson G
    Cancer Treat Rep; 1979 Aug; 63(8):1303-9. PubMed ID: 476707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
    Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
    J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen in patients with breast or colon cancer.
    Lee YN
    West J Med; 1978 Nov; 129(5):374-80. PubMed ID: 364839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.
    Repetto L; Onetto M; Gardin G; Costanzi B; Giudici S; Vitiello E; Merlini L; Naso C; Zannini C; Paganuzzi M
    Cancer Detect Prev; 1993; 17(3):411-5. PubMed ID: 8402728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA.
    Janku F; Srovnal J; Korinkova G; Novotny J; Petruzelka L; Power D; Matous B; Hajduch M
    Neoplasma; 2008; 55(4):317-22. PubMed ID: 18505343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
    Pompecki R; Schröder G; Garbrecht M; Frahm H
    Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative borderline elevated CEA predicts for earlier relapse in patients with rectal cancer receiving adjuvant postoperative therapy.
    Dawson LA; Franssen E; Davey P
    Cancer J Sci Am; 1999; 5(6):374-9. PubMed ID: 10606480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.